Keyphrases
Relative Contribution
100%
CD8+ T Cells
100%
West Nile Virus
100%
Vaccine-induced Immunity
100%
West Nile Encephalitis
100%
Encephalitis Virus
100%
Plasmid DNA (pDNA)
80%
Survival Rate
40%
West Nile Virus Vaccine
40%
Genetic Deficiency
20%
Neutralizing Antibodies
20%
Two-dose
20%
Specific Antibodies
20%
Virus-like
20%
Virus-neutralizing Antibody
20%
Human Use
20%
Flavivirus
20%
Neurotropic
20%
Complete Protection
20%
Antibody Titer
20%
High Survival
20%
Protective Immunity
20%
Vaccine Response
20%
Mosquito-borne
20%
Central Nervous System Infections
20%
Whole-cell Vaccine
20%
Virus Challenge
20%
Immune Protection
20%
Antigen-specific CD8+ T Cells
20%
Formalin
20%
Inactivated Vaccine
20%
Prime-boost Strategy
20%
Acquired Deficiency
20%
Single-dose Vaccine
20%
Commercial Vaccines
20%
Immunology and Microbiology
Cytotoxic T-Cell
100%
West Nile Virus
100%
Encephalitis Virus
100%
Plasmid
80%
Survival Rate
40%
West Nile Vaccine
40%
Antigen Specificity
20%
Neutralizing Antibody
20%
Virus-Like Particle
20%
Central Nervous System
20%
Flavivirus
20%
Antibody Titer
20%
Inactivated Vaccine
20%
Inactivated Virus Vaccine
20%
Infection
20%